Mural Oncology (MURA) Institutional Ownership $2.61 -0.02 (-0.76%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$2.59 -0.02 (-0.80%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Mural Oncology (NASDAQ:MURA)CurrentInstitutional OwnershipPercentage80.21%Number ofInstitutional Buyers(last 12 months)26TotalInstitutional Inflows(last 12 months)$14.79MNumber ofInstitutional Sellers(last 12 months)13TotalInstitutional Outflows(last 12 months)$2.64M Get MURA Insider Trade Alerts Want to know when executives and insiders are buying or selling Mural Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MURA Institutional Buying and Selling by Quarter Mural Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/29/2025 Concurrent Investment Advisors LLC22,500$28K0.0%N/A0.131% 2/18/2025Alpine Global Management LLC80,964$261K0.1%-61.6%0.476% 2/17/2025Squarepoint Ops LLC175,502$565K0.0%+1.4%1.031% 2/17/2025Two Sigma Advisers LP26,000$84K0.0%N/A0.153% 2/17/2025Two Sigma Investments LP65,150$210K0.0%+12.0%0.383% 2/17/2025Prosight Management LP466,822$1.50M0.4%-18.2%2.743% 2/17/2025Millennium Management LLC168,255$542K0.0%-11.1%0.989% 2/17/2025Bridgeway Capital Management LLC29,300$94K0.0%N/A0.172% 2/17/2025Acorn Capital Advisors LLC1,286,079$4.14M2.3%N/A7.556% 2/14/2025Jane Street Group LLC21,117$68K0.0%N/A0.124% Get the Latest News and Ratings for MURA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mural Oncology and its competitors with MarketBeat's FREE daily newsletter. 2/14/2025Northern Trust Corp39,966$129K0.0%+22.0%0.235% 2/14/2025RBF Capital LLC338,669$1.09M0.1%-5.9%1.990% 2/14/2025Price T Rowe Associates Inc. MD26,905$87K0.0%-28.6%0.158% 2/14/2025Alpine Global Management LLC80,964$261K0.1%-61.6%0.476% 2/13/2025Raymond James Financial Inc.56,176$181K0.0%N/A0.330% 2/13/2025Renaissance Technologies LLC238,465$768K0.0%+17.4%1.401% 2/12/2025Geode Capital Management LLC181,029$583K0.0%-4.7%1.064% 2/12/2025Nicollet Investment Management Inc.94,737$305K0.1%-4.3%0.557% 2/11/2025Virtu Financial LLC40,025$129K0.0%N/A0.235% 2/6/2025Raymond James Financial Inc.56,176$181K0.0%N/A0.330% 1/13/2025 FNY Investment Advisers LLC15,000$48K0.0%-25.0%0.088% 11/16/2024Geode Capital Management LLC190,056$595K0.0%+2.6%1.115% 11/15/2024RBF Capital LLC359,900$1.13M0.1%-7.3%2.112% 11/15/2024Point72 Asset Management L.P.108,715$340K0.0%N/A0.638% 11/15/2024Centiva Capital LP203,706$638K0.0%-9.3%1.195% 11/15/2024Point72 Asia Singapore Pte. Ltd.12,574$39K0.0%-52.8%0.074% 11/14/2024Verition Fund Management LLC340,000$1.06M0.0%-33.4%1.996% 11/13/2024BNP Paribas Financial Markets28,048$88K0.0%-71.0%0.165% 11/13/2024FMR LLC20,580$64K0.0%+124.7%0.121% 11/9/2024Primecap Management Co. CA140,045$438K0.0%-40.5%0.822% 11/8/2024Commerce Bank12,423$39K0.0%N/A0.073% 9/16/2024Cubist Systematic Strategies LLC31,243$98K0.0%N/A0.185% 9/16/2024Point72 Asia Singapore Pte. Ltd.26,642$84K0.0%N/A0.157% 8/15/2024Armistice Capital LLC1,688,000$5.30M0.1%N/A9.974% 8/15/2024Point72 Asia Singapore Pte. Ltd.26,642$84K0.0%N/A0.157% 8/14/2024Squarepoint Ops LLC167,644$526K0.0%N/A0.991% 8/14/2024Cubist Systematic Strategies LLC31,243$98K0.0%N/A0.185% 8/13/2024Canada Pension Plan Investment Board22,360$70K0.0%N/A0.132% 8/9/2024Primecap Management Co. CA235,551$740K0.0%N/A1.392% 8/9/2024Renaissance Technologies LLC232,100$729K0.0%N/A1.371% The Man I Turn to In Times Like This (Ad)A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.Market chaos? Hear Tilson’s take now8/9/2024Dimensional Fund Advisors LP22,563$71K0.0%N/A0.133% 8/8/2024Nicollet Investment Management Inc.98,016$308K0.1%N/A0.579% 8/6/2024Acadian Asset Management LLC318,536$998K0.0%N/A1.882% 8/5/2024BBR Partners LLC10,000$31K0.0%N/A0.059% 8/1/2024 Rhumbline Advisers10,786$34K0.0%N/A0.064% 7/9/2024 Harbor Capital Advisors Inc.36,769$115K0.0%N/A0.217% (Data available from 1/1/2016 forward) MURA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MURA shares? During the previous two years, 35 institutional investors and hedge funds held shares of Mural Oncology. The most heavily invested institutionals were Armistice Capital LLC ($5.30M), Acorn Capital Advisors LLC ($4.14M), Prosight Management LP ($1.50M), RBF Capital LLC ($1.09M), Verition Fund Management LLC ($1.06M), Acadian Asset Management LLC ($998K), and Renaissance Technologies LLC ($768K).Learn more on MURA's institutional investors. What percentage of Mural Oncology stock is owned by institutional investors? 80.21% of Mural Oncology stock is owned by institutional investors. Learn more on MURA's institutional investor holdings. Which institutional investors have been buying Mural Oncology stock? Of the 26 institutional investors that purchased Mural Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($1.69M), Acorn Capital Advisors LLC ($1.29M), Acadian Asset Management LLC ($318.54K), Renaissance Technologies LLC ($267.50K), Primecap Management Co. CA ($235.55K), Squarepoint Ops LLC ($170.11K), and Raymond James Financial Inc. ($112.35K). How much institutional buying is happening at Mural Oncology? Institutional investors have bought a total of 4,684,823 shares in the last 24 months. This purchase volume represents approximately $14.79M in transactions. Which Mural Oncology major shareholders have been selling company stock? Of the 13 institutional investors that sold Mural Oncology stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Alpine Global Management LLC ($259.25K), Verition Fund Management LLC ($170.85K), Prosight Management LP ($103.80K), Primecap Management Co. CA ($95.51K), BNP Paribas Financial Markets ($68.69K), RBF Capital LLC ($49.47K), and Millennium Management LLC ($20.96K). How much institutional selling is happening at Mural Oncology? Institutional investors have sold a total of 832,438 shares in the last 24 months. This volume of shares sold represents approximately $2.64M in transactions. Related Companies Esperion Therapeutics Institutional Ownership Actuate Therapeutics Institutional Ownership Journey Medical Institutional Ownership Innate Pharma Institutional Ownership TuHURA Biosciences Institutional Ownership AC Immune Institutional Ownership Canopy Growth Institutional Ownership Molecular Partners Institutional Ownership Korro Bio Institutional Ownership Inhibikase Therapeutics Institutional Ownership This page (NASDAQ:MURA) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mural Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.